|
| Medical Degree: |
M.D.
|
|---|
| Degree: |
Ph.D.
|
|---|
| Mailing Address: |
1124 West Carson Street J-3
mailbox 453
Torrance, CA 90502
UNITED STATES
|
|---|
| Mailing Address: |
mail box 453
UNITED STATES
|
|---|
| Work Address: |
Harbor-UCLA Medical Center, Bldg J-3 1000 West Carson Street
Torrance, CA 90509
CA
UNITED STATES
|
|---|
|
Fax Number:
|
(310) 320-2564
|
|---|
|
Work Phone Number:
|
(310) 222-2217
|
|---|
|
|
Geller ML, Chlebowski RT HT and breast cancer risk.
Fertil Steril.
2003; 80 Suppl 4:
5-9.
Chlebowski RT The American Cancer Society guide for nutrition and physical activity for cancer survivors: a call to action for clinical investigators..
CA: a cancer journal for clinicians. .
2003; 53(5):
266-7.
Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR American society of clinical oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
J Clin Oncol.
2005; 23(3):
619-29.
Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E Estrogen plus progestin and colorectal cancer in postmenopausal women..
The New England journal of medicine. .
2004; 350(10):
991-1004.
Chlebowski RT, Col N Menopausal hormone therapy after breast cancer.
Lancet.
2004; 363(9407):
410-1.
Chlebowski RT, Kim JA, Col NF Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy..
Seminars in oncology. .
2003; 30(6):
776-88.
Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
J Clin Oncol.
2003; 21(21):
4042-57.
Harris RE, Chlebowski RT, Jackson RD, Frid DJ, Ascenseo JL, Anderson G, Loar A, Rodabough RJ, White E, McTiernan A Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative..
Cancer research. .
2003; 63(18):
6096-101.
Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL Re: Short-interval follow-up mammography: are we doing the right thing?.
Journal of the National Cancer Institute. .
2003; 95(15):
1175-6.
Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
J Clin Oncol.
2003; 21(13):
2597-9.
Yasmeen S, Romano PS, Pettinger M, Chlebowski RT, Robbins JA, Lane DS, Hendrix SL Frequency and predictive value of a mammographic recommendation for short-interval follow-up..
Journal of the National Cancer Institute. .
2003; 95(6):
429-36.
|
|
|
